A scientific evaluation of VIP in experimental autoimmune encephalomyelitis (the MS model) discovered that VIP administration reduced medical severity scores by 40–sixty five% across twelve impartial scientific studies, with histological Evaluation showing diminished CNS infiltration of Th1 and Th17 cells and enhanced Foxp3+ Tregs from the spinal